☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
spasticity
Metacel Pharmaceuticals' Ozobax (baclofen) Receives the US FDA's Approval for Spasticity Due to Multiple Sclerosis
September 18, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.